memantine hydrochloride

FDA Drug Profile — memantine hydrochloride, Memantine Hydrochloride, MEMANTINE

memantine hydrochloride is listed in the FDA National Drug Code directory with 44 NDC codes, marketed under brand names including memantine hydrochloride, Memantine Hydrochloride, MEMANTINE. Available dosage forms: tablet, capsule, extended release, tablet, film coated, tablet, coated, kit.

Drug details

Generic Name
memantine hydrochloride
Brand Names
memantine hydrochloride, Memantine Hydrochloride, MEMANTINE
Application Number
NDA021487
Sponsor
Actavis Pharma, Inc.
NDC Codes
44
Dosage Forms
TABLET, CAPSULE, EXTENDED RELEASE, TABLET, FILM COATED, TABLET, COATED, KIT, SOLUTION
Routes
ORAL
Active Ingredients
MEMANTINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Memantine hydrochloride extended-release capsules are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride is a N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.